Fady Malik

16PUBLICATIONS
161CO-AUTHORS
Medical devicesCardiology (incl. cardiovascular diseases)Epidemiological modellingLegal ethicsRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jan 19, 2026
The Use of Durable Medical Equipment in COURAGE-ALS, a Phase 3, Multicentre, Randomized Clinical Trial for ALS.

Stacy A Rudnicki, Elisa Giacomelli, Katherine Herder

|Dec 05, 2025
Efficacy and Safety of Aficamten in Children and Adolescents With Obstructive Hypertrophic Cardiomyopathy: Study Design and Rationale of CEDAR-HCM.

Juan Pablo Kaski, Paul F Kantor, Stephanie J Nakano

|Sep 05, 2025
Characterization and Application of Novel Exercise Recovery Patterns That Reflect Cardiac Performance: A Substudy of the SEQUOIA-HCM Trial.

Joseph Campain, Catharine Griskowitz, Chloe Newlands

|Jun 27, 2025
Participant, site personnel and sponsor perspectives on decentralized trial features in COURAGE-ALS: a randomized clinical trial.

Stacy A Rudnicki, Paulos Gebrehiwet, Stuart Kupfer

|Sep 01, 2024
Cardiac biomarkers and effects of aficamten in obstructive hypertrophic cardiomyopathy: the SEQUOIA-HCM trial.

Caroline J Coats, Ahmad Masri, Roberto Barriales-Villa

|Aug 28, 2024
Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy.

James J Hartman, Darren T Hwee, Julien Robert-Paganin

Pageof 3

Frequent Collaborators

10 joint publications

Stuart Kupfer

5 joint publications

Stephen B Heitner

4 joint publications

Scott D Solomon

4 joint publications

Darren T Hwee